Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6118748 | International Journal of Infectious Diseases | 2012 | 4 Pages |
Abstract
The association with fluoroquinolone exposure suggests that measures to reduce unnecessary use may be an effective preventative strategy. Known colonization with ESBL-E is a strong risk factor for ESBL-E bacteremia, and colonization status should be taken into consideration when choosing empirical therapy.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Joshua T. Freeman, Stephen J. McBride, Mitzi S. Nisbet, Greg D. Gamble, Deborah A. Williamson, Susan L. Taylor, David J. Holland,